$13.5 million awarded in Dana-Farber Cancer Institute death
The family of a 40-year-old woman who died following a cycle of experimental chemotherapy at the Dana-Farber Cancer Institute in Boston was awarded a total of $13.5 million. The jurors decided that her death could have been prevented if Dana-Farber doctors had investigated the cause of chronic diarrhea that surfaced during an unusual treatment protocol for a tumor behind her knee.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- 3 Traits Personality Assessments Can't Reveal
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Carondelet to Pay $35M to Settle Fraud Allegations
- CHS Hacked, 4.5M Patient Records Compromised